FIG. 1.

TR6 mRNA expression in resting or stimulated immune cells. B cells were treated for 18 to 20 h with LPS (5 μg/ml) or S. aureus Cowan I (SAC) (10⁻⁵ dilution), T cells were treated with PHA (5 μg/ml) or immobilized anti-CD3 (1 μg/ml) and anti-CD28 (10 μg/ml) MAb, NK cells were treated with IL-2 (100 U/ml) and IL-12 (5 ng/ml), and monocytes (Mon.) were treated with LPS (100 ng/ml). TR6 mRNA expression was evaluated by quantitative RT-PCR. Results for one of three donors are shown.